Outlive
LongevityResearchHub

How bats' virus defenses may hold secrets to extreme longevity

Extensive longevity and DNA virus-driven adaptation in nearctic Myotis bats

TL;DR

Researchers sequenced genomes from 8 related bat species and found that bats evolved special adaptations to fight DNA viruses—and these same adaptations appear linked to cancer resistance and extended lifespans. This suggests that the ability to tolerate viruses without inflammation may be a key mechanism underlying why some bats live 3-4 times longer than similarly-sized mammals.

Credibility Assessment Preliminary — 29/100
Study Design
Rigor of the research methodology
6/20
Sample Size
Whether the study was sufficiently powered
6/20
Peer Review
Review status and journal reputation
3/20
Replication
Has this finding been independently reproduced?
5/20
Transparency
Funding disclosure and data availability
9/20
Overall
Sum of all five dimensions
29/100

What this means

This early-stage work suggests that bats' extreme longevity may stem from evolved adaptations that let them tolerate viruses peacefully—and these same genes protect against cancer. It's an intriguing hypothesis that could inspire new drug research, but it's not yet peer-reviewed and needs experimental proof before we know if it's true.

Red Flags: Preprint status (not peer-reviewed). Small sample size (8 species, ~50 individuals estimated). Functional validation limited to in vitro cell cultures—no whole-organism or in vivo studies. Claims about pleiotropic mechanisms are inferred from comparative genomics, not experimentally proven in living bats. High citation count (6) for a very recent preprint is unusual and warrants checking whether citations are predominantly self-citations or from preprint servers. No mention of data availability or preregistration.

Bats are biological outliers: some live 40+ years despite weighing only a few grams, far outliving mice or rats of similar size. They also tolerate viruses (like coronaviruses) that would kill other mammals, without getting sick. This raises a fundamental question: are these traits connected, and what genetic changes enable them? This preprint from Vazquez, Sudmant, and colleagues tackled that question by comparing genomes of 8 closely related Myotis bat species with known lifespan variation (ranging from ~5 to 35+ years).

The researchers generated high-quality genome assemblies and cell lines from these species, then conducted genome-wide screens for positive selection—genetic changes that have been consistently favored by evolution. They also examined structural variations (large insertions, deletions, duplications) and ran functional experiments in primary bat cells. The key finding: bats show widespread positive selection in genes involved in DNA virus interaction, which is unusual compared to other mammals. Separately, they found high rates of copy number variation in RNA virus genes. Most intriguingly, they identified distinct evolutionary pathways: DNA virus adaptation appears to involve point mutations (positive selection), while RNA virus adaptation uses structural duplication/deletion strategies.

They also discovered pervasive positive selection in cancer-related pathways across long-lived Myotis species, and demonstrated that primary cells from the longest-lived species (M. lucifugus, living 40+ years) show unique DNA damage responses. The authors propose a "pleiotropic" mechanism—meaning the same genes that help bats tolerate viruses without mounting destructive immune responses also suppress cancer and support DNA repair, thereby extending lifespan.

Limitations are important to note: this is a preprint (not yet peer-reviewed), which means claims have not undergone formal expert scrutiny. The sample is relatively small (8 species, likely <50 individuals total), and functional experiments are limited to cell culture—not whole-organism studies. The mechanistic link between virus tolerance and longevity remains correlative; causality has not been proven. Additionally, findings from bats may not directly translate to humans, although understanding the principles could inform drug discovery.

Why this matters for longevity research: if virus tolerance and longevity are genuinely linked through immune regulation, this could open new avenues for geroprotective drugs that dampen chronic inflammation without compromising infection defense. It also provides a natural experiment showing that extreme longevity *without* caloric restriction or other known interventions is possible, hinting at alternative biological pathways. However, readers should treat these findings as promising preliminary work requiring replication in peer-reviewed form and functional validation before drawing clinical conclusions.

View Original Source

0 Comments